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One of the most distressing things that can happen to an
author is to have a manuscript rejected by JACC despite the
fact that the reviews seem fairly positive. As the editor of
JACC, I am the recipient of phone calls, letters, faxes, and
e-mail that ask some form of the question: “Why did JACC
reject my manuscript?” Although the reasons are always
related to the manuscript in question, there are other general
factors that are also important. These are outlined below in
the hopes that disappointed authors may better understand
some of the reasons for rejection:
A. The numbers. The number of manuscripts received by
JACC continues to rise in the face of an essentially fixed
number of pages. Thus, our rejection rate must continue to
rise. Since we first took over editorship of JACC eight and
a half years ago, our acceptance rate has steadily dropped
from 30% to its current level of about 17%. This is a
daunting number. The dilemma of what to accept is evident
each Tuesday morning when I meet with the Associate
Editors to review those manuscripts that we think are
potentially worthy of publication in JACC. Each week we
can select about eight manuscripts that we expect to have
revised and eventually accepted for publication. However,
after our presentations and discussions, we may have up to
16 manuscripts that we consider of sufficient quality to
publish in JACC. We then must undergo the painful task of
paring the 16 down to 8, rejecting 8 good manuscripts per
week. This decision is usually based on our “priority”
overview of the potential importance of the manuscript to
the field and how many of JACC ’s readers would find the
paper interesting. These decisions reflect our best collective
judgment but are no consolation to an author whose
manuscript is rejected. One fall-back position is to hold over
one or more of these manuscripts for a week to see if they
compete more favorably with next week’s batch. Experience
has taught us, however, that the chances for a held-over
manuscript are rarely better the next week.
B. Content. The membership of the ACC are mostly adult
cardiologists; therefore, the bulk of the articles are directed
to that constituency. However, we need to keep a proper
balance among the many different areas of cardiology.
Because our membership is mostly clinically oriented, only
about 10% of our papers come from the animal laboratory,
and these should have an obvious relationship to clinical
cardiology. During our tenure, we have also decided not to
accept case reports. These content issues play an important
role in our overall decision making.
C. Science and the importance of the question. The most
important consideration in accepting a manuscript for JACC
is that the question be important and the scientific method
be strong. Ideally such a manuscript would either: 1) report
a large, prospective, randomized, double-blind, placebo-
controlled trial that is addressing a very important clinical
question; 2) make a compelling demonstration of the
efficacy of a new procedure; or 3) present experimental
studies that illuminate underlying mechanisms of cardiovas-
cular disease and therapy. We appreciate that these types of
studies are not frequent enough to fill the pages of JACC.
Accordingly, we also consider observational studies or pilot
studies worth publishing if their content is deemed to be of
great interest to clinical cardiologists. Sometimes we accept
a controversial or provocative manuscript, which may spur
other investigators to validate an unexpected new finding.
We are less interested in “methods” papers, but they rank
more highly if they are used to answer a clinical question.
We are almost always subconsciously asking ourselves the
question, “What do our readers want?” I am also trying to
judge whether our readers will exclaim, “Wow, that was
interesting!” after reading a specific article.
D. Statistics. One of our associate editors (SG) carefully
examines the statistical methods of a manuscript to assure us
that the results are valid and meaningful. Although there is
sometimes an in-depth criticism of statistical methods,
requiring substantial revision of the manuscript, rarely does
this alone disqualify a manuscript.
E. The reviews. We routinely solicit at least two reviewers
for each manuscript. When the initial reviews differ mark-
edly, we frequently obtain a third or arbiter review. There
are three important parts to a good review of an article. First
is a ranking of the originality, methodology, and presenta-
tion; and an overall priority rating (top 10%, top 25%, top
50%, bottom 50%, reject.) The second are the confidential
comments to the editor, which can be very helpful in
judging the manuscript. Frequently these are not totally
consistent with what the reviewer writes to the authors. The
third are the comments of the reviewers that are sent back
to the authors. Not uncommonly, a manuscript may have a
rating of bottom 50% or reject, and yet it may have fairly
benign comments to the authors. For example, a study may
be well done but mostly confirmatory of previous work and,
therefore, be of lower priority. Although the review system
is not perfect, we are heavily influenced in our decisions by
the evaluations of expert reviewers.
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Although the above are not the only elements that
enter into our decision making, they describe the major
factors. We apologize in advance if we reject some of your
good work because we do not have the space to publish
every meritorious manuscript we receive; but we look
forward to publishing studies of yours that are of the high
quality we are trying to attain in JACC. As always, we
invite your comments and suggestions regarding the
editorial process.
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